Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer

Latest results from the STAMPEDE trial show that adding abiraterone to androgen deprivation therapy improved both metastasis-free and overall survival.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news